PARIS, October 23, 2023 Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces that it has presented its progress on the EFICAS clinical trial at the 36th "Journées de La Pitié" national conference on heart and lung transplantation and circulatory assistance, organized by the cardi
A clinician recently reviewed the evidence about whether exposure to dust mites, smoking, vitamin D, probiotics, and other factors influences the risk of asthma in an unborn child.
Gradual resumption in Aeson implantations in line with progressive production ramp-up over the year 2023 Cash position of €51 million as of December 31, 2022 and active exploration of financing
CARMAT Provides a Business Update and Communicates Its Financial Targets for the First Time streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.